SAB Biotherapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 06/08/2026 | Mar 2026Filed 06/08/2026 | Sep 2025Filed 14/11/2025 | Jun 2025Filed 06/08/2026 | Mar 2025Filed 06/08/2026 | Sep 2024Filed 14/11/2025 | Jun 2024Filed 14/11/2025 | Mar 2024Filed 14/11/2025 |
|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | $0.3 | $0.9 | |
| −$22 | −$19 | $45 | −$10 | −$5.2 | −$10 | −$7.3 | −$5 | |
| −$0.28 | −$0.35 | −$0.21 | −$1.09 | −$0.56 | −$1.12 | −$0.79 | −$0.54 | |
| 80 | 54 | 78 | 9.3 | 9.3 | 9.3 | 9.3 | 9.2 |
Trend